简体中文 | 繁體中文 | English

Trade Shows News

2020-01-06 18:17 Sharp at CES 2020: Realizing an 8K+5G Ecosystem
2020-01-06 14:12 Ambarella Enables Artificial Intelligence on a Wide Range of Connected Cameras Using Amazon SageMaker Neo
2020-01-03 17:15 Taiwanese Puppetry Master Chen Hsi-huang Brings Puppets Into Life
2020-01-03 16:52 Esri Joins HERE Technologies at CES 2020
2020-01-03 16:50 Glimpses of Taiwan in the 1960s: Photographs by American Pastor
2020-01-03 15:03 New Shared Mobility Concept, Luxoft HALO, Introduces a Revolutionary Digital, Consumer-Grade In-Vehicle Experience
2020-01-03 14:49 Luxoft Joins Microsoft Connected Vehicle Platform Ecosystem to Accelerate Delivery of Connected Vehicle Solutions
2020-01-03 14:41 Hualien Elders Assemble Local Memories Into Art
2020-01-02 13:36 Velodyne Lidar Advances Driver Safety with New Products at CES 2020
2019-12-23 14:47 O-RAN Alliance Conducts First Global Plugfest to Foster Adoption of Open and Interoperable 5G Radio Access Networks
2019-12-20 17:58 Mary Kay Inspires Beauty Trends at Spring/Summer 2020 Fashion Weeks in Europe
2019-12-20 17:32 The Royal Commission for AlUla Launches Its Second Winter at Tantora Festival of Culture, Heritage and Celebration in Saudi Arabia
2019-12-17 14:34 CES Asia Call for Speakers Now Open
2019-12-16 09:42 MagikEye to Demonstrate Invertible Light™ Image Sensor Technology at CES
2019-12-12 16:56 Final results from the NuProtect study demonstrating efficacy of Nuwiq® (simoctocog alfa) in previously untreated patients (PUPs) presented at ASH 2019
2019-12-12 16:29 Seattle Genetics and Takeda Announce Additional Analyses of ADCETRIS® (Brentuximab Vedotin) ECHELON-1 and ECHELON-2 Phase 3 Clinical Trials at the 2019 ASH Annual Meeting
2019-12-11 16:37 GSMA Announces First Details for MWC Shanghai 2020
2019-12-11 16:05 Takeda Demonstrates Its Long-Standing Commitment to Advancing Treatments for Rare Bleeding Disorders with Studies Highlighting Real-World Evidence and Investigational Gene Therapy at ASH 2019
2019-12-11 11:15 Takeda to Present Results from the Phase 3 TOURMALINE-AL1 Trial of NINLARO in Patients with Amyloidosis
2019-12-05 15:23 Healthcare+ Expo Taiwan 2019 Exhibitor Profiles

Business Wire Weibo

Press Releases

Latest Releases